Molecular Analysis for Therapy Choice (MATCH)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, lymphoma, and myeloma
This trial is available at multiple Sutter Locations pleasecontact one of the following about Study Match EAY 131
CPMC (San Francisco) firstname.lastname@example.org
PAMF (Peninsula/South Bay) Tanya Pozniansky email@example.com
REDI (East Bay) Vivian Leong Leongv@sutterhealth.org
SIMR (Sacramento/Valley Area):Sacramento: Please contact Rodrigi@sutterhealth.org firstname.lastname@example.org
Modesto: Please contact MassonD@sutterhealth.org andPalosA@sutterhealth.org
Solano-Vallejo Cancer Center: Please email@example.com
View study details on ClinicalTrials.gov
February 01, 2017
Investigator(s): Ellis C. Dillon, Ph.D.
Breast Tumor and Blood markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up
Investigator(s): Su-Ying Liang, Ph.D.